5 replies to this topic

[lan]

Anybody out there who has any experience using serrapeptase and / or nattokinase for heart-related problems and its effect of heart rhytm / arrhythmia?

Thank you.

[Lufega]

I tried both and all I got was difficulty breathing. Hey, at least I know it's doing something

[A case of pneumonitis due to serrapeptase]
[Article in Japanese]

Hirahara K, Saitoh T, Terada I, Uno K, Nagai A, Kioi S, Arakawa M.

Abstract
A case of pneumonitis due to Serrapeptase was described. A 69-year-old man was treated with Serrapeptase for 16 days because of common cold, then fever, nonproductive cough and dyspnea developed and chest X-ray revealed diffuse fine granular shadows in bilateral lung fields. Once the administration of Serrapeptase was halted, symptoms, chest X-ray abnormalities and laboratory data improved markedly. The fraction of lymphocytes increased in bronchoalveolar lavage fluid and OKT4/T8 decreased. Microscopic examination of transbronchial lung biopsy showed interstitial pneumonia. Both leukocyte migration inhibition test and sensitized hemagglutination test were positive for Serrapeptase. Based on these findings, we diagnosed this case as Serrapeptase-induced pneumonitis.

PMID: 2693781 [PubMed - indexed for MEDLINE]

[FunkOdyssey]

Yeah serrapeptase messed with my breathing / lungs as well. Serrapeptase has a unique mucolytic effect that can be detrimental.

I take nattokinase and bromelain without problems.

[MoodyBlue]

The amino acid Taurine is needed to regulate heart rythmn, so taking it in supplemental form might help if you have arrythmia problems. I only take it because it has a synergistic effect with the glucuronolactone supplement I take. Here is a research result: http://george-eby-re...rrhythmias.html and more valuable info: http://www.vrp.com/a...aspx?ProdID=351.

[pycnogenol]

I didn't have any heart problems when I was taking serrapeptase but it sure messed up a chronic condition of mine a few years ago so I stopped.

Ray Sahelian has some information on both:

http://www.raysaheli...attokinase.html

http://www.raysaheli...rrapeptase.html

[bobman]

I had good luck with Arjuna terminalia. After a couple of orthopedic surgeries I developed a serious enough heart condition that was initially diagnosed as ARVD by a senior cardiologist at MGH (via echo-cardiogram). I had very frequent palpitations, constant chest pain, and very poor endurance. Right ventricle hypertrophy showed up clearly on the echo. After about 1 month after starting Arjuna I had a followup MRI. No hypertrophy, no fatty infiltration, and my ejection volume was good enough to avoid a clinical diagnosis. I no longer have palpitations more frequently than once a week or so, and no more chest pain. I'm less out of breath as well. Here is a study examining its effects on Class IV heart failure patients: http://www.ncbi.nlm..../pubmed/7649665\

"Twelve patients with refractory chronic congestive heart failure (Class IV NYHA), related to idiopathic dilated cardiomyopathy (10 patients); previous myocardial infarction (one patient) and peripartum cardiomyopathy (one patient), received Terminalia Arjuna, an Indian medicinal plant, as bark extract (500 mg 8-hourly) or matching placebo for 2 weeks each, separated by 2 weeks washout period, in a double blind cross over design as an adjuvent to maximally tolerable conventional therapy (Phase I). The clinical, laboratory and echocardiographic evaluation was carried out at baseline and at the end of Terminalia Arjuna and placebo therapy and results were compared. Terminalia Arjuna, compared to placebo, was associated with improvement in symptoms and signs of heart failure, improvement in NYHA Class (Class III vs. Class IV), decrease in echo-left ventricular enddiastolic (125.28 +/- 27.91 vs. 134.56 +/- 29.71 ml/m2; P < 0.005) and endsystolic volume (81.06 +/- 24.60 vs. 94.10 +/- 26.42 ml/m2; P < 0.005) indices, increase in left ventricular stroke volume index (44.21 +/- 11.92 vs. 40.45 +/- 11.56 ml/m2; P < 0.05) and increase in left ventricular ejection fractions (35.33 +/- 7.85 vs. 30.24 +/- 7.13%; P < 0.005). On long term evaluation in an open design (Phase II), wherein Phase I participants continued Terminalia Arjuna in fixed dosage (500 mg 8-hourly) in addition to flexible diuretic, vasodilator and digitalis dosage for 20-28 months (mean 24 months) on outpatient basis, patients showed continued improvement in symptoms, signs, effort tolerance and NYHA Class, with improvement in quality of life.(ABSTRACT TRUNCATED AT 250 WORDS)"

Edited by bobmann, 21 June 2010 - 04:39 AM.